98P Efficacy and safety of durvalumab plus gemcitabine and cisplatin in Chinese participants with advanced biliary tract cancer: Extension cohort of the phase III, randomised, double-blind, placebo-controlled, global TOPAZ-1 study

S. Qin,J-Q. Cai, E. Li, B. Xing, L. Zhao, C. Dai, J. Li, Y. Shen,Z. Chen,L. Liu,Z. Lu, A. Zang, Y. Bai,H. Liang, J. Liang,X. Liu, J. Wang,M-H. Chen, R. Miao, X. Qu

Annals of Oncology(2023)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要